Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach

The outbreak of COVID-19 caused by the coronavirus (SARS-CoV-2) prompted number of computational and laboratory efforts to discover molecules against the virus entry or replication. Simultaneously, due to the availability of clinical information, drug-repurposing efforts led to the discovery of 2-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhu, Navya B., Vinay, Chigateri M., Satyamoorthy, Kapaettu, Rai, Padmalatha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491670/
https://www.ncbi.nlm.nih.gov/pubmed/36164436
http://dx.doi.org/10.1007/s13205-022-03363-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491670/
https://www.ncbi.nlm.nih.gov/pubmed/36164436
http://dx.doi.org/10.1007/s13205-022-03363-4

Ejemplares similares